CareDx, Inc. (CDNA), Monday reported preliminary loss for the fourth quarter and a 30 percent increase preliminary revenues.
For the quarter, the company projects loss to be approximately $32 to $34 million and adjusted EBITDA to be between $8 and $9 million.
Quarterly preliminary revenue is expected to increase to a range of $85 to $86 million.
Meanwhile, for the full year 2024, loss is estimated to be between $58 million and $60 million and revenue is expected to be between $332 million to $333 million.
Looking forward to the fiscal year 2025, CareDx sees revenue of $370 million.
In the pre-market hours, CareDx's stock is trading at $25.08, up 6.14 percent on the Nasdaq.
For comments and feedback: editorial@rttnews.com